The impact of gut microbiome and diet on post-acute sequelae of SARS-CoV-2 infection.
Reyes, Zabrina, Stovall, Mary Catherine, Punyamurthula, Sanjana et al. · Journal of the neurological sciences · 2024 · DOI
Quick Summary
This study looked at how gut bacteria and diet might affect people who develop Long COVID (symptoms that continue months after a COVID-19 infection). Researchers reviewed existing studies to see if changes in gut bacteria linked to worse COVID illness could be improved by eating foods rich in fiber and antioxidants, like those in the Mediterranean Diet. The idea is that a healthier gut might help prevent or reduce Long COVID symptoms.
Why It Matters
Understanding the gut microbiome's role in PASC is relevant to ME/CFS research because both conditions share features like post-exertional malaise and multisystem involvement, and both may involve dysregulation of the gut-brain axis. This study identifies dietary interventions as potentially modifiable risk factors, offering ME/CFS patients practical strategies that could complement medical care. The proposed gut microbiome mechanism provides a biologically plausible link between infection, immune dysregulation, and chronic symptom persistence.
Observed Findings
Reduced gut microbiome diversity is associated with increased severity during acute COVID-19 infection.
Gut microbiome changes persist long-term after acute SARS-CoV-2 infection.
Fiber-rich diets increase gut microbial diversity and short-chain fatty acid production.
The Mediterranean Diet demonstrates anti-inflammatory and neuroprotective effects in studied populations.
Alterations in microbiome composition may increase susceptibility to post-acute sequelae development.
Inferred Conclusions
Long-term dysbiosis after acute COVID-19 infection may be a risk factor for PASC development.
Nutritional interventions—particularly fiber-rich and Mediterranean dietary patterns—may modulate microbiome composition to reduce PASC risk.
The gut-brain axis represents a plausible mechanistic pathway linking microbiome health to post-viral neurological symptoms.
Targeting diet and microbiome health may offer a modifiable prevention or management strategy for PASC.
Remaining Questions
Do specific dietary interventions reduce PASC incidence or severity in prospective clinical trials?
What This Study Does Not Prove
This systematic review does not establish causation—it identifies associations between microbiome changes and PASC severity based on existing studies. The study does not provide direct clinical trial evidence that specific diets prevent or treat Long COVID or ME/CFS in humans, nor does it rule out that microbiome changes are secondary consequences rather than primary drivers of PASC. Results are correlational and require prospective intervention trials to validate therapeutic benefit.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →